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Abstract
In 404 Lep
ob/ob F2 progeny of a C57BL/6J (B6) x DBA/2J (DBA) intercross, we mapped a DBA-related quantitative trait locus
(QTL) to distal Chr1 at 169.6 Mb, centered about D1Mit110, for diabetes-related phenotypes that included blood glucose,
HbA1c, and pancreatic islet histology. The interval was refined to 1.8 Mb in a series of B6.DBA congenic/subcongenic lines
also segregating for Lep
ob. The phenotypes of B6.DBA congenic mice include reduced b-cell replication rates accompanied
by reduced b-cell mass, reduced insulin/glucose ratio in blood, reduced glucose tolerance, and persistent mild
hypoinsulinemic hyperglycemia. Nucleotide sequence and expression analysis of 14 genes in this interval identified a
predicted gene that we have designated ‘‘Lisch-like’’ (Ll) as the most likely candidate. The gene spans 62.7 kb on Chr1qH2.3,
encoding a 10-exon, 646–amino acid polypeptide, homologous to Lsr on Chr7qB1 and to Ildr1 on Chr16qB3. The largest
isoform of Ll is predicted to be a transmembrane molecule with an immunoglobulin-like extracellular domain and a serine/
threonine-rich intracellular domain that contains a 14-3-3 binding domain. Morpholino knockdown of the zebrafish paralog
of Ll resulted in a generalized delay in endodermal development in the gut region and dispersion of insulin-positive cells.
Mice segregating for an ENU-induced null allele of Ll have phenotypes comparable to the B.D congenic lines. The human
ortholog, C1orf32, is in the middle of a 30-Mb region of Chr1q23-25 that has been repeatedly associated with type 2
diabetes.
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Introduction
Type 2 diabetes (T2D) afflicts ,246 million people worldwide,
including ,21 million in the United States (7% of the population);
another 54 million Americans are pre-diabetic. If the incidence of
T2D continues to increase at the present rate, one in three
Americans, and one in two minorities born in 2000 will develop
diabetes in their lifetimes [1]. Direct medical costs associated with
diabetes in the United States exceed $132 billion a year [2], and
consume ,10% of health care costs in industrialized nations.
Peripheral hyporesponsiveness to insulin increases metabolic
demands on the insulin-producing b-cells of the pancreatic islets.
Many obese individuals are insulin-resistant, but do not become
overtly diabetic provided that the increased demand for insulin is
effectively met [3,4]. However, if b-cell mass and/or function are
insufficient to meet this requirement, overt hyperglycemia and
T2D ensue [5]. In autopsy series of subjects with T2D, total b-cell
mass is decreased [6,7]. Primary reductions of b-cell mass
predispose to diabetes in rodent models [8,9,10] and in autosomal
dominant forms of diabetes (e.g., MODY; maturity onset diabetes
of youth) [11]. Such primary reductions might predispose to some
instances of T2D.
Susceptibility to T2D is strongly inherited as evidenced by the
.80% concordance rates in monozygotic twins [12,13,14,15],
familial aggregation, and ethnic predispositions [16]. Heritability
of sub-phenotypes related to T2D, e.g. insulin resistance and b-cell
hypofunction is even higher [17]. Environmental factors are also
important [17,18]. Although several genes for relatively rare
monogenic forms of diabetes, including MODY, syndromic
(Wolfram syndrome), lipoatrophic, and mitochondrial-inherited
diabetes have been identified [2,19], the underlying genetic bases
for the genetically complex T2D, accounting for .95% of diabetes
patients, have remained elusive. The identification of susceptibility
genes is made difficult by the polygenic nature of the phenotype
[20], its reflection of convergent, distinct metabolic processes
producing identical phenotypes (phenocopies), and the potent
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characterize the disease. Clear genetic influences on the
endophenotypes (intermediate phenotypes) of b-cell mass/function
and insulin resistance have been shown, and vary among racial
groups. [21,22,23,24]. Some notable earlier successes (e.g. PPARG,
CAPN10), and a recent series of genome-wide association studies of
large numbers of well-phenotyped subjects [25,26,27,28,29,30,31]
have identified T2D susceptibility loci/genes (e.g. TCF7L2) whose
functions with regard to the implicated phenotypes are uncertain.
As no single implicated gene or allele accounts for more than a
small fraction of risk to develop T2D, there are still many genes/
molecular mechanisms awaiting identification.
In mice, there is striking strain-dependent susceptibility to T2D
in the context of obesity [32]. We exploited the differential
diabetes susceptibilities of the B6 and DBA strains segregating for
the obesity mutation Lep
ob [32] to identify a diabetes susceptibility
QTL in B6xDBA progeny and then used congenic lines derived
from the implicated interval to clone a candidate gene accounting
for the QTL. Similar strategies have been used to identify QTLs
(and responsible genes) for other complex phenotypes in mice [33]
such as type 1 diabetes [34], diet-induced obesity [35], tuberculosis
susceptibility [36], atherosclerosis [37], epilepsy [38], schizophre-
nia [39] and, also, T2D [40,41,42,43].
We identified, ‘‘Lisch-like’’ (Ll), a novel gene, encoding multiple,
tissue-specific transcripts in brain, liver and islets. The functional
consequences of the hypomorphic DBA allele (diabetes-prone) in
Lep
ob/ob mice appear to be late embryonic to early postnatal
reductions in b-cell mass due to diminished rates of b-cell replication,
some ‘‘catch-up’’ of b-cell mass by 2–3 months, followed by mild
glucose intolerance at .6 months of age. These phenotypes are
recapitulated in mice with an ENU-induced null allele of Ll.
Results
Genetic Map of Diabetes QTL and Related Congenic
Lines
We identified a QTL for diabetes-related phenotypes in obese
F2 and F3 progeny of an intercross between diabetes-resistant
C57BL/6J (B6) and diabetes-susceptible DBA/2J (DBA) mice
segregating for Lep
ob. Phenotypes including fasting blood glucose,
HbA1c and islet histology mapped with LOD .8 around
D1Mit110 on distal Chr 1 at 169.6 Mb (details in Methods:
Mapping T2D-related Phenotypes). By producing congenic and
sub-congenic B6.DBA lines also segregating for Lep
ob, we refined
the interval to 5.0 Mb between rs31968429 at 168.1 Mb and
rs31547961 at 173.1 Mb where all four congenic lines overlap for
DBA (Figure 1; details in Methods: B6.DBA Congenic Lines:
Creation and Fine Mapping).
We further restricted the search (Figure 1) by identifying a
haplotype block [44] conserved between B6 and DBA that extends
3.2 Mb from rs30708865 at 169.9 Mb to rs31547961 at
173.1 Mb. Only eleven unvalidated B6 vs. DBA single nucleotide
polymorphisms (SNPs) in this interval are listed in the Mouse SNP
database (www.ncbi.nlm.nih.gov/SNP/MouseSNP.cgi); however,
among fragments we could amplify containing nine of these
putative SNPs, we detected no sequence variants. Moreover, we
found no coding sequence/expression difference between B6 and
DBA among all genes and transcripts in the ‘‘conserved’’ interval
by computation, direct sequencing, and quantitative mRNA
expression analysis. Thus, it is unlikely that the variant(s) in the
genetically-defined interval with peak at 169.6 Mb mediating
differential diabetes susceptibility between these two strains is
within the ‘‘conserved region.’’ We sequenced the 3 kb interval
between rs31968429 and rs33860076 at the centromeric end of
subcongenic line 1jcdt and detected no variants between the two
strains. Therefore, we focused our efforts on the 1.8 Mb B6 vs.
DBA ‘‘variable’’ interval, between rs33860076 at 168.1 Mb and
rs30708865 at 169.9 Mb.
Metabolic and Anatomic Phenotypes of Congenic Lines
The congenic/sub-congenic lines shown in Figure 1 displayed
phenotypes of hypoinsulinemic hyperglycemia in association with
relative reductions in b-cell mass due to reduced b-cell
proliferation (see Islet Morphology and b-cell Replication and
Apoptosis). Phenotypes were generally more salient in male
animals. Genotype in the congenic interval (B6 or DBA) per se
did not affect their body weight or composition. Supporting
experiments are described below.
By 4 weeks of age, fasting plasma glucose was elevated in Lep
ob/ob
males who were D/D (DBA/DBA) for the congenic interval 1jcd
and fed standard (9% fat) chow; glucose concentrations were
higher up to 120 days. After 120 days, there were no significant
differences in fasting glucose between D/D (DBA/DBA) and B/B
(B6/B6) mice (Figure 2A). The decline in pre-prandial blood
glucose levels in Lep
ob/ob males between 90 and 200 days is
probably attributable to a slight expansion of b-cell mass in
response to transient insulin resistance occurring as a normal
consequence of sexual maturation (,60 days of age) [9,45]. To
examine diabetes susceptibility in D/D animals that were obese
independent of leptin deficiency, we fed lean (Lep
+/+) 1jcd males a
high-fat diet (60% kcal from fat) for 13 weeks, starting at 7 weeks
of age. These mice became more hyperglycemic than B/B mice
(Figure 2B), showing a persistence of this difference – similar to the
animals in 2A – up to age ,140 days when the study ended.
To delineate differences in acute glucose handling in D/D vs.
B/B animals, we used intraperitoneal glucose tolerance testing
(ipGTT). At 60 days (Figure 2C), and even up to 200 days, when
the study ended (Figure 2D), Lep
ob/ob 1jcdc males were less glucose
tolerant than B/B. The relative reduction in glucose tolerance in
D/D vs. B/B animals that are not overtly diabetic is likely related
to reduction in the number of islets. The occurrence of the
diabetes-related phenotype is independent of Lep
ob, since 100-day
Author Summary
Type 2 diabetes (T2D) accounts for over 90% of instances
of diabetes and is a leading cause of medical morbidity
and mortality. Twin studies indicate a strong polygenic
contribution to susceptibility within the context of obesity.
Although approximately ten genes making important
contributions to individual risk have been identified, it is
clear that others remain to be identified. In this study, we
intercrossed obese, diabetes-resistant and diabetes-prone
mouse strains to implicate a genetic interval on mouse
Chr1 associated with reduced b-cell numbers and elevated
blood glucose. We narrowed the region using molecular
genetics and computational approaches to identify a novel
gene we designated ‘‘Lisch-like’’ (Ll). The orthologous
human genetic interval has been repeatedly implicated in
T2D. Mice with an induced mutation that reduces Ll
expression are impaired in both b-cell development and
glucose metabolism, and reduced expression of the
homologous gene in zebrafish disrupts islet development.
Ll is expressed in organs implicated in the pathophysiology
of T2D (hypothalamus, islets, liver, and skeletal muscle)
and is predicted to encode a transmembrane protein that
could mediate cholesterol transport and/or convey signals
related to cell division. Either mechanism could mediate
effects on b-cell mass that would predispose to T2D.
Molecular Cloning of Lisch-like
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+/+ 1jc D/D males fed the Surwit (high fat, high sucrose)
diet for 10 weeks were also less glucose tolerant than littermate B/
B males (Figure 2E).
Hyperglycemia due to relative hypoinsulinemia, was evident in
1jc Lep
ob/ob D/D animals fed a chow diet as early as 4 weeks
(Figure 3A). At mean ages of 30- and 62-days, age-adjusted plasma
insulin concentrations per mg blood glucose were lower in D/D
than in B/B animals. This difference was due to lower plasma
insulin in D/D (p=0.0004) and not higher blood glucose in D/D
(p=0.916). Consistent with these ratios, D/D Lep
+/+ males showed
a 40% decrease in insulin secretion when clamped at a blood
glucose level of 250 mg/dl for an hour (Figure 3B). No difference
in insulin sensitivity was detected by euglycemic – hyperinsulin-
emic clamping (data not shown).
Consistent with their hypoinsulinemic hyperglycemia, 21-day
old 1jcd D/D males had smaller islets than their B/B counterparts
(Figure 4A). A qualitative cell-autonomous b-cell defect in insulin
secretion, however, is unlikely to be the primary functional defect
in D/D animals, since islets isolated from 28-day old 1jcd D/D
males responded to graded glucose concentrations (2.8 mM–
16.8 mM) or 10 mM arginine by secreting amounts of insulin
comparable to age- and sex-matched B/B littermates (Figure 4B).
Also consistent with insulin/glucose ratios and hyperglycemic
clamp results, isolated islets from 60-day old 1jc Lep
ob/ob males fed
normal chow and 100-day old 1jc Lep +/+ on the Surwit diet
showed reduced insulin secretion at 2.8 mM and 5.6 mM
[glucose] in D/D vs. B/B littermates. For reasons indicated
below, the early glucose intolerance of D/D mice is probably due,
in part, to a deficiency of b-cell mass.
Islet Morphology and b-cell Replication and Apoptosis
The fractional area of the pancreas accounted for by b-cells [46]
in Lep
ob/ob 1jcd males was examined in 20-, 60- and 150-day old
mice. By 60 days a trend to reduced b-cell area was apparent in D/
D, and by 150 days of age, b-cell mass of the 1jcd D/D sub-
congenics was about half that of B/B littermate controls. B/D
animals had b-cell masses that were about two-thirds of B/B
littermate controls (Figure 5A). These findings are consistent with in
vivodata showingonset ofelevated bloodglucose (see Figure2A) and
lower circulating insulin concentrations (relative to glucose) in D/D
sub-congenics at ,60 days of age (see Figure 3A), and persistence of
decreasedglucosetoleranceat200daysofage.Thelowerrelativeb-
cell mass in D/D animals reflects fewer numbers of b-cells, rather
than smaller sized b-cells. There were no differences in pancreatic
weight between D/D and B/B male animals.
To assess the basis for the difference in b-cell mass by 60 days,
we measured rates of b-cell replication and apoptosis. We co-
stained pancreatic sections in 1jcd congenic 1- and 21-day old
Lep
ob/ob male mice with antibodies to insulin and Ki67 antigen, a
nuclear marker of proliferation expressed during all stages of the
Figure 1. Genetic Map of Sub-Congenic Lines for Diabetes-Related Phenotypes in the Interval Chr 1 164–194 Mb. Genetic map shows
sub-congenic lines (1jc, 1jcdc, 1jcd, 1jcdt) in the interval Chr1:164–194 Mb that display hypoinsulinemic hyperglycemia in association with
histological evidence of a relative reduction in b-cell mass in the first 21–28 days of life due to reduced b-cell proliferation. An expanded view of the Ll
gene (chr1.1224.1) is shown at bottom. Above the map scale, in black type, are microsatellite markers that were used to genotype B6 and DBA alleles
to establish general boundaries of these congenic intervals. D1mit110 is the peak of the F2/F3 QTL linkage map (see Mapping T2D-related
Phenotypes in B6xDBA F2/F3 Progeny). Below map scale, RefSNP (rs) and D-markers in red type identify DBA sequence limits of the respective
congenic lines. Markers in blue type identify the closest, confirmed non-DBA (B6) sequence. Sequences in intervals between markers in red and blue
type are DBA vs. B6 invariant. Gray bars are DBA-derived sequences. Yellow box corresponds to a 3.2 Mb interval, conserved between DBA and B6.
The red box identifies the N-scan predicted gene, chr1.1224.1, subsequently identified as Lisch-like (Ll), extending centromerically from line 1jcdt. In
the expanded view of Ll, the B6 boundary (rs31968429) for lines 1jcdc, 1jcd, 1jcdt is 333 bp centromeric of exon 7; the DBA boundary, (rs33860076) is
2,700 bp telomeric of exon 7. 5330438I03Rik is an anti-sense transcript described in detail in the text. Marker positions are from the mouse genome
annotation (NCBI Build 36, February 2006).
doi:10.1371/journal.pgen.1000137.g001
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b-cells, we normalized the number of Ki67 positive b-cells to the
total number of insulin positive cells. Groups consisted of 4 B/B
and 4 D/D 1-day old mice or 4 B/B, and 8 D/D 21-day old mice.
In 1-day old D/D males, the rate of b-cell replication was ,1/3
that of B/B littermates, whereas there was no difference in 21-day
old animals due to normally reduced b-cell replication by the time
of weaning (Figure 5B) [48,49,50].
The proportion of small islets (250–2000 mm
2) in 21-day old
Lep
ob/ob males was greater in D/D (1jc and 1jcd) mice (73%) than
in B/B (60%); whereas the proportion of large islets (10,000–
50,000 mm
2) was lower (9% in D/D and 14% in B/B). This
finding is consistent with the b-cell replication studies in P1 mice
(Figure 5B), and recently reported evidence that new b-cells are
derived from replication of pre-existing b-cells [51].
In 13-day old 1jc mice, when b-cell apoptosis is active [52], we
did not detect significant differences between B/B and D/D islets
in b-cell apoptosis using a TUNEL assay [53] and caspase-3
staining [54] (data not shown). Thus, the lower number of b-cells
in D/D mice is primarily a result of lower rates of proliferation of
b-cells in the perinatal period.
Genes in the Minimal DBA Interval Conveying Diabetes
Susceptibility
To identify all genes in the minimal DBA variable interval, (see
above for definition) we screened 277 genes and transcripts,
computationally predicted by GenScan, TwinScan, FGeneSH,
Otto, or SGP2 that map to the interval. We excluded 50 single-
exon transcripts (probably pseudogenes [55]) that did not belong
to a transcript cluster and were not homologous to transcripts in
the syntenic human interval, and 16 ribosomal gene transcripts,
unique to this interval, that could not be specifically amplified due
to their genomic redundancy, and manually curated the remaining
211 predicted transcripts. We rejected 63 that did not amplify in
RNA/cDNA pools from multiple organs/ages of B6 and DBA
mice (see Methods: Testing for Predicted Transcripts in cDNA
Pools) and, using BLASTn, clustered the remaining 148 transcripts
into 14 groups. These, correspond to 11 known genes and 3
predicted genes that we validated by amplification in cDNA pools.
Figure 2. Fasting Blood Glucose and Glucose Tolerance Tests in Congenic Lines. A) Blood glucose in Lep
ob/ob males congenic for the
interval 1jcd (BB; homozygous for B6; DD; homozygous for DBA in the interval) and fed regular mouse chow diet (9% fat) ad libitum. Determinations
made following a 4 h morning fast. 4–13 animals per genotype group. B) Blood glucose in Lep
+/+ males congenic for the interval 1jcd and fed high fat
diet (60% of calories as fat) ad libitum for 13 wks, starting at 7 wks of age. Determinations made following a 4 h morning fast. C) ipGTT in 60-day old
Lep
ob/ob males congenic for the interval 1jcdc. D) ipGTT in 200-day old Lep
ob/ob males congenic for the interval 1jcdc. E) ipGTT in 14-wk old male Lep
+/+
males congenic for the interval 1jc who had been fed the ‘‘Surwit’’ diet for 10 wks. In all panels, * indicates p,0.05 (2 tailed t-test for genotype effect
of congenic interval; mean is +/2SEM.
doi:10.1371/journal.pgen.1000137.g002
Figure 3. Plasma Insulin/Glucose Ratios and Hyperglycemic
Clamps in Age-Grouped 1jc Congenic Males. A) Fasting plasma
insulin/glucose ratios in 30- and 62-day old 1jc Lep
ob/ob B/B and D/D
male mice, chow-fed since weaning. Raw data are shown in Table S1.
Asterisk (*) indicates significant difference between B/B and D/D
animals; p-value ,0.05 for 2-tailed t-test. B) Hyperglycemic clamping in
100-day old 1jc males on Surwit Diet for 18 weeks. 1jc DD male mice fed
a Surwit diet for 18 wks were clamped at a blood glucose concentration
of 250 mg/dl for 1 hr and serum insulin concentrations measured at
1 hr. Asterisk (*) indicates p-value ,0.05 for 2-tailed t-test.
doi:10.1371/journal.pgen.1000137.g003
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Mael and Pbx1 (Figure 6). We analyzed all transcripts in the entire
‘‘variable’’ region.
Analysis of Genes in the Variable Interval
The genetic variation accounting for differential diabetes-
susceptibility in mice segregating B/B vs. D/D in the congenic
intervals could be due to: 1) coding sequence variant(s) that alter
the amino acid sequence of a protein(s); 2) regulatory variants,
including anti-sense transcripts that affect expression and stability,
and 39 untranslated region (UTR) variants; or 3) splicing variants.
We investigated all hypotheses.
Non-Synonymous Sequence Variants
To identify all non-synonymous B6 vs. DBA sequence variants in
the ‘‘variable’’ interval, we collected genomic sequence for B6 and
DBA strains from databases at NCBI and Celera [56], filled gaps
using bi-directional sequencing to achieve 100% coverage of all
coding sequences in both strains, and validated coding sequence
variants by bi-directionally re-sequencing gene fragments encom-
passing each variant in both B6 and DBA strains. Consequently, we
identified five non-synonymous single nucleotide variants: one in
each of three FMO-like (flavin mono-oxygenase) genes, and two in
chr1.1224.1 (Figure 6). The latter gene, we designated ‘‘Lisch-like’’
(Ll) because of its sequence similarity to a gene in mouse and rat,
formerly known as Lisch7 (http://rgd.mcw.edu/), butnow known as
Lsr (lipolysis stimulated receptor).
Computational analysis of LL and the three FMO-like proteins
using SNAP [57], PolyPhen [58], SIFT [59], PAM250 matrix
substitution weights [60] and PROFacc [61] predicted that all of the
amino acid substitutions were benign with respect to function. The
SNAP scores obtained for our variant alleles, -1 (FMO13, K282E), -2
(FMO12, V239I), -3 (LL, A647V), and -6 (LL, T587A; FMO9,
Q5R), indicate that there is a ,60%, ,69%, ,79%, and ,90%
respective chance of the non-synonymous variants being neutral.
Similarly, PolyPhen classified all variations as ‘‘benign’’ and SIFT
scores were well above 0.05 (neutral). PAM weights of 0 and above
suggest interchangeability of the respective amino acids throughout
evolution. The % differences were low, suggesting that the DBA and
B6 variants are equally likely to occur in related sequences (see
Methods: Computational Methods for Evaluating Effects of nsSNPs).
Expression Differences
We used Affymetrix microarrays to quantify those transcripts in
the minimum congenic interval that we had validated by PCR-
amplification (see Methods: Testing for Predicted Transcripts in
cDNA Pools). We examined hypothalamus, islets, liver, soleus and
EDL (extensor digitorum longus) skeletal muscle from DD and BB
Lep
ob/ob congenic animals (see Methods: Microarray Gene
Expression Analysis). These arrays did not contain elements for
all of the 14 genes we confirmed in the interval: missing from the
array were the 3 FMO genes. Therefore, we also used real-time
qPCR, to quantify expression of each gene and confirmed
transcript in tissues and organs central to diabetes (pancreatic
islets, liver, skeletal muscle, adipose tissue and hypothalamus) in
90-day old male Lep
ob/ob 1jc D/D and B/B animals (see Methods:
Figure 4. Relationship between Islet Histology and Insulin Secretion. A) Islet histology in 21-day old 1jcd Lep
ob/ob B/B and D/D male mice.
4 mm pancreatic sections from 21-day old 1jcd Lep
ob/ob B/B and D/D male mice were insulin-stained with anti-guinea pig IgG and visualized by light
microscopy at 106magnification. In D/D animals, islets were smaller and less numerous. By histomorphometry, the proportion of small islets (250–
2000 mm
2) in 21-day old Lep
ob/ob males was greater in D/D (1jc and 1jcd) mice (73%) than in B/B (60%); whereas the proportion of large islets (10,000–
50,000 mm
2) was lower (9% in D/D and 14% in B/B). B) In vitro glucose-stimulated insulin secretion in pancreatic islets in 28-day old 1jc Lep
ob/ob B/B
and D/D males. Each congenic genotype group consisted of 3 male animals. Negative control consisted of 3 4-week old diabetes-prone Lepr
db/db KsJ
male animals that are hypo-responsive to glucose stimulation [9]; positive control was 3 4-week old insulin-resistant animals segregating for a
diabetes-susceptibility QTL on Chr5 at 78cM, characterized by hyperglycemia and hyperinsulinemia. B/B and D/D show dose response, but no B/B vs.
D/D difference at any concentration of glucose. Response to 10 mM arginine in the same animals confirms that the b-cells of the B/B and D/D
congenics are comparable with regard to insulin release to a non-glucose stimulus. The 0 mM arginine control in B/B is shown to establish baseline
insulin levels.
doi:10.1371/journal.pgen.1000137.g004
Figure 5. b-Cell Mass and Replication Rates in 1jcd Lep
ob/ob
Males. A) Relative b-cell area in 20-, 60, and 150-day old Lep
ob/ob males
segregating for B and D 1jcd congenic intervals. In 60 and 150-day old
males segregating for the D/D sub-congenic interval, relative b-cell
mass was approximately half that of B/B littermates; B/D animals were
intermediate at 150 days. N=10 for each of the 3 groups of animals.
Mean+/2SEM. The asterisk (*) indicates that p,0.05 for D/D vs. B/B at
60 days, and D/D and B/D vs B/B at 150 days. These findings are
consistent with in vivo data (see Figure 2C) showing onset of elevated
blood glucose at rest and during ipGTT by 60 days. B) b-cell replication
rates (Ki67) in 1- and 21-day old Lep
ob/ob B/B and D/D 1jcd males. To
estimate the proportion of dividing cells, the number of Ki67-positive b-
cells was normalized to the total number of insulin-positive cells.
Replication of b-cells in 1-day old D/D males was ,1/3 that of B/B
littermates (p=0.017). This difference, not present in 21-day old
animals, was probably due to normally reduced b-cell replication by
the time of weaning. Mean+/2SEM. The asterisk (*) indicates that
p,0.05 for D/D vs. B/B in 1-day old animals.
doi:10.1371/journal.pgen.1000137.g005
Molecular Cloning of Lisch-like
PLoS Genetics | www.plosgenetics.org 5 July 2008 | Volume 4 | Issue 7 | e1000137real time qPCR). Results of the microarray and qPCR
experiments are shown in Table 1 and summarized in Figure 7A.
Among genes in the region, including Lmx1a [62], and Rxrg
[63], that constitute candidates for susceptibility to T2D, we
identified no non-synonymous SNPs (nsSNPs) and no multi-organ
differences in expression levels between B/B and D/D animals.
The most prominent and consistent differences in expression we
did observe were for chr1.1224.1 (Ll), which was two to four-fold
lower in 21-day old Lep
ob/ob D/D mice than in B/B mice in the
diabetes-relevant tissues/organs by microarray analysis and up to
twenty-fold lower by qPCR (Figure 7A). (We later show that Ll
protein in hypothalamus is strikingly reduced in 1jc D/D vs. B/B;
see Figure 11A). The difference in Ll gene expression in liver
persists with age (Figure 7B) as does the difference in glucose
tolerance in response to overt glucose challenge (see Figure 2D).
Whether the differences in hepatic Ll expression are mechanisti-
cally related to differences in glucose homeostasis are unknown at
this point; LL may influence hepatic gluconeogenesis, or the
hepatic differences could simply mirror parallel and more
physiological relevant changes in b-cells.
We also detected (by PCR) Ll transcripts in e7, e11, e15, and
e17 whole mouse embryos, and in testis, kidney, heart, lung,
uterus, eye, thymus and spleen. For the anti-sense interval between
intron 9 and intron 7 (see below and Figures 1 and 8), we found
higher expression levels in liver and hypothalamus of D/D v. B/B
animals. This difference is consistent with a possible suppressive
role for the D/D anti-sense transcript (see below). The Aldh9a1
gene, known to be highly expressed in human embryonic brain
and involved in glycolysis and fatty acid metabolism, showed
qualitative changes comparable to those seen in Ll. The mapping
experiment that identified the interval of mouse Chr1 containing
statistical signals related to T2D phenotypes would be expected to
enrich for regions in which several genes might contribute to the
phenotypes. Although Aldh9a1 may be such a gene, we chose to
focus initially on Ll, since it showed the most striking quantitative
differences in expression between D/D and B/B animals.
‘‘Lisch-like’’ (Ll) Gene Structure and Splice Variants
Complete Gene Sequence. To identify 39 and 59 UTRs
flanking the isolated transcripts of Lisch-like (Ll), we mapped each
transcript onto the UCSC Mouse Genome Browser (http://
genome.ucsc.edu/) and included contiguous 59 and 39 ESTs. The
Ll gene spans 62,714 bp on mouse Chr. 1, from 168,090,795–
168,153,508 (Figure 8). The full-length, 10-exon transcript,
isoform 1 (iso1), is 8,279 nucleotides. It comprises a 301 nt 59
non-coding sequence, a 1941 nt coding sequence (including stop
codon), encoding a 646 amino acid polypeptide, and a 6,037 nt 39
UTR. The predicted protein includes a cleavable, signal peptide
(SP; exon 1), an extra-cellular domain (ECD; exons 2–4), a trans-
membrane domain (TMD; the amino-half of exon 5), and a large
intra-cellular domain (ICD; from the cysteine-rich, carboxy-half of
exon 5–exon 10). Exons 2 and 3 of the ECD are immunoglobulin-
like (Ig-like) V-type domains. Exon 6 is proline-rich and the ICD is
overall serine/threonine-rich.
Isoforms. We isolated complete transcripts for 7 isoforms of
Ll by PCR amplification of cDNAs using primer-pairs flanking the
first and last predicted exons (see Methods: Cloning and
Sequencing of Lisch-like Isoforms). We identified 4 major
isoforms shown in Figure 8 and 3 minor isoforms. Exons 5 and
6 are absent in iso5; exon 9 is absent in iso6; and exons 5–9 are
absent in iso7.
59 Upstream Interval. The 59 upstream interval shown
(Figure 8A) includes 569 nt upstream of the predicted first
transcribed base of the 59 UTR. A CpG island is predicted to
overlap the 59 UTR. By sequencing this interval in DBA BAC
95f9 (MM_DBA library, Clemson University Genomics Institute;
www.genome.clemson.edu/), we discovered 8 DBA vs. B6
nucleotide variants not in the public database. Of these, only
one variant, (a C to T substitution within a CpG island) is outside a
repeat element.
Anti-sense Interval. An unspliced 2,845 nt anti-sense
transcript (Figure 8B) of Ll, from adult male mouse B6 pituitary
gland (5330438I03Rik; red bar in Figure 1), starts 42 bp telomeric
of exon 9, crosses exons 9 and 8, and terminates in the intron
between exons 7 and 8. This transcript (see Figure 7A) is expressed
2–3 fold higher in DBA vs. B6 in hypothalamus and liver. The
centromeric end of the anti-sense transcript is just 506 bp from
rs33860076 at the centromeric end of the region of DBA overlap
among congenic lines 1jcd, 1jcdt and 1jcdc. An open reading
frame (ORF) encodes a predicted polypeptide of 271 amino acids,
Figure 6. Genes in the Minimal Congenic Interval on Chr1:168.1–170.3 Mb. Gray background corresponds to the minimal DBA ‘‘variable’’
interval from 168.1 Mb–169.9 Mb, between markers rs33860076 and rs30708865. Yellow background corresponds to the centromeric end of the DBA
vs. B6 ‘‘conserved’’ interval (i.e. nominally invariant). Genes in blue are from RefSeq; genes in black are predicted and locally confirmed as described in
the text. The N-scan predicted gene chr1.1224.1 is designated here as ‘‘Lisch-like’’. Amino acid variants are shown in red to the right of the
corresponding gene. Nucleotide substitutions were confirmed by bidirectional sequencing in both C57BL/6J and DBA/2J DNA.
doi:10.1371/journal.pgen.1000137.g006
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segments in anti-sense strands of Ll in other species. The interval
contains 45 DBA vs. B6 variants, five of which, underlying exon 9,
are listed in dbSNP. One newly discovered variant in the intron
preceding exon 8, is an insertion in DBA of a 37 nt unique
sequence that is homologous to a sequence in an intron of the
mouse otoancorin gene on chromosome 7 and to an intronic
sequence of an N-scan predicted gene on chromosome 11.
39 UTR. Of 52 B/D sequence variants in the long (6 kb) 39
UTR of the Ll transcript (Figure 8C), 20 were newly discovered by
our ‘‘in-house’’ sequencing.
Cross-Species Comparisons of Ll Sequence
From the Ensembl database, we identified zebra fish orthologs
of Ll and Lsr. The clustalW pair-wise similarity scores for the
predicted protein coded for by the zebra fish gene zgc:114089 (Lsr
ortholog) is 42 vs, the mouse LSR protein, and 29 vs. the mouse
LL protein. The similarity scores for the predicted protein coded
for by the zebra fish gene zgc:110016 (Lisch-like ortholog) are 36 vs.
LL and 28 vs. LSR. We performed clustalW analysis (Figure 9)
between the mouse LL-iso1 protein and three related proteins: 1)
the human C1orf32 protein at 1q24.1 (chr.1 165,154,620–
165,211,185; NCBI Build 36.1), which is the product of a gene
highly expressed in the developing human retina and brain [64]; 2)
the predicted protein sequence for the zebra fish Lisch-like ortholog,
zgc:110016 located on zebra fish chromosome 9 at 31.6 Mb; and
3) the mouse LSR protein, transcribed from a gene on
chromosome 7 at 30.7 Mb. Pair-wise similarity scores for the
intact proteins and major domains are shown in the legend. The
human homolog is similar throughout, but diverges slightly in the
Table 1. BB/DD Transcript Ratios of Genes in the Variable Interval 168.1–169.9 Mb.
BB/DD Transcript ratio
Confirmed Genes
a Liver Brain Islets EDL Soleus Muscle Adipose
m-array
b,c,d,e qPCR
f.g m-array qPCR m-array qPCR m-array m-array qPCR qPCR
chr1.1224.1 2.5 20
h 1.7 2.0 2.9 3.0 2.6 4.1 2.9 2.7
(Lisch-like) 9610
24 5610
27 2610
23 4610
24 7610
24
Lisch-like antisense 0.5 0.3 NE
i NE NE
6610
23 3610
29
Tada1l 1 1.4 1.4 0.9 0.9 1.05 1.1 0.9 0.5 1.1
NS
j 1610
28 NS NS NS
Pogk 0.9 1.3 0.8 0.73 1.0 1.2 1.0 0.9 0.7 1.05
NS 1610
23 NS NS NS
FMO13 Not on array - inclusive-only
k,l
FMO12 Not on array - inclusive-only
k,l
FMO9 Not on array - inclusive-only
k,l
C030014K22 NE 1.1 NE 1.9 NE NE NE NE 1.4 1.1
Uck2 NE 1.4 0.6 0.8 1.4 1.2 1.0 1.3 0.7 0.8
NS 2610
22 NS NS
Tmco1 0.8 1.5 0.9 0.8 0.7 1.0 0.8 0.9 0.7 1.5
2610
25 3610
24 2610
24 2610
22 3610
22
Aldh9a1 1.4 1.3 1.5 1.4 1.9 1.5 1.6 1.7 1.3 1.6
1610
26 3610
27 4610
25 3610
24 3610
22
Mgst3 0.4 1.0 0.6 0.6 1.3 0.8 0.7 0.8 0.6 0.7
1610
29 2610
28 NS 7610
26 NS
Lrrc52 NE NE NE NE NE
Rxrg NE 0.7 NE 1.6 NE 1.0 1.2 NE 0.9 1.0
NS
Lmx1a NE nd NE 2.0 NE 0.9 NE NE 1.0 1.7
aBoldface indicates RefSeq gene; regular type is locally-confirmed, predicted transcript.
bExpression profiling was carried out using Affymetrix #430A mouse gene chips.
cTen 21-day old DD and BB Lep
ob/ob 1jc congenic males were analyzed.
dRatio is average B/B signal divided by average D/D signal in the organ.
eLower line in m-array box is p-value, 2-sided t-test, comparing each set of 10 BB and 10 DD mice in the same organ.
fSamples for qPCR prepared from 5 BB and 5 DD 90-day old Lep
ob/ob 1jc males on 2 occasions.
gRatios represent relative numbers of transcripts (BB/DD).
hPrimer-pairs amplify transcripts of Ll isoforms 1, 2, 4, and 5; these comprise .90% of Ll transcripts.
iExpression not detected.
jNot significant (p.0.05).
kInclusive-only transcripts were detected in a cDNA pool that included whole embryos, 1-day old pups, and other tissues, but not in the cDNA pool prepared from
diabetes-relevant organs.
lProbes for these genes were neither on the Affymetrix #430A nor analyzed by qPCR.
doi:10.1371/journal.pgen.1000137.t001
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proteins are most alike in the TMD, less so in the Ig-like domain,
and most dissimilar in the ICD. The Lsr protein has a short
extension to exon 6, and no exon 8 equivalent. Ll and Lsr also have
splicing patterns similar to the mouse Ildr1 (Ig-like domain
receptor 1) gene [65], and the proteins they encode all belong to
the Lisch7 family (IPR008664; www.ebi.ac.uk/interpro).
Knockdown of Ll and Lsr Orthologs in Zebra Fish
To assess the function of Ll in islet/b-cell ontogenesis, we
examined expression patterns and the effects of morpholino-
mediated knockdown in zebra fish embryos. Morpholinos are
modified anti-sense oligonucleotides that produce a strong
hypomorphic ‘‘knockdown’’ phenotype [66] either by inhibiting
proper splicing of the pre-RNA transcript [66] or by ATG-
blocking of translation [67]. Morpholino knockdown has been
used to demonstrate a role for the endocrine hormones GnRH,
GHRH and PACAP during development [68,69,70,71]. Many of
the molecular mechanisms regulating pancreas development
appear to be conserved among zebra fish and other vertebrates
[72], and the single zebra fish islet provides an excellent model of
vertebrate development.
Using whole mount in situ hybridization (Figure 10A), we
observed that the Lisch-like ortholog zgc:110016 was expressed in
the brain and otocyst by 48 hours post fertilization (hpf), and by
72 hpf expression was evident in the intestine. The Lsr ortholog
zgc:114089, located on Chr 15 at 39.0 Mb, was expressed in
pancreas at 48 and 72 hpf, (similar to our postnatal observations in
mouse with Ll), intestine, liver, pharynx, pronehphros and otocyst
for 48 hpf (72 hpf not shown), and, at 34 hpf, in both pancreatic
buds. Since the anterior bud gives rise to exocrine tissue,
pancreatic duct, and a small number of endocrine cells, while
the posterior bud gives rise only to endocrine tissue [69],
expression of the Lsr-like paralog throughout this stage is consistent
with a role in the ontogeny of pancreatic endocrine tissue.
The close structural similarities among Lisch-related genes (see
Figure 9) suggested that functional data on both zebra fish genes
could be physiologically relevant and, therefore, we studied the
involvement in islet development of both orthologs. We injected
(in separate experiments) morpholinos for both genes into embryos
Figure 7. Expression Analysis of Candidate Genes and Liver Expression of Lisch-like. A) Tissue-specific expression analysis of genes in the
‘‘variable’’ portion of the minimum congenic interval. Data for relative expression (B/B to D/D) from Table 1 for hypothalamus, islets, liver and EDL-
muscle are displayed graphically and numerically below the graph. 21-day old DD and BB Lep
ob/ob 1jc congenic males were analyzed using Affymetrix
#430A microarrays. B) Liver expression of Lisch-like in 1jc B/B and D/D males from 21–120 days. Samples from Lep
ob/ob 1jc males were analyzed by
qPCR.
doi:10.1371/journal.pgen.1000137.g007
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PLoS Genetics | www.plosgenetics.org 8 July 2008 | Volume 4 | Issue 7 | e1000137Figure 8. Predicted Structure of Ll Gene with Expanded Views of Critical Regions. Lisch-like gene (middle of figure) is the full-length, 10-
exon, splice variant (iso1) and includes 872 bp upstream of the transcriptional start site. Predicted domains are below exons. Exon 1 includes the 59
UTR (narrow orange bar) and cleavable signal peptide (SP). Exons 2–4 are extra-cellular, within which exons 2–3 code for an Ig-like domain. Exon 5
includes the TMD with a very cysteine-rich cluster in the carboxyl half; exons 6–10 code for a serine- and proline-rich intracellular domain; exon 10
also includes a long 39 UTR. The ‘‘xs’’ identify exons deleted in isoforms 2–4. A. 59 upstream interval (expanded view); Black bars correspond to BLAT
displays vs. the reference B6 genome. DBA variants are below the DBA bar. Annotations are composites of displays from the UCSC Genome Browser
on Mouse February 2006 Assembly. Royal blue peaks correspond to sequences with predicted ESPERR regulatory potential (http://www.bx.psu.edu/
projects/esperr). The darker blue blocks correspond to evolutionarily conserved sequences, from the UCSC ‘‘Conservation’’ track. Lighter blue blocks
show positions of simple sequence motifs, with the consensus motif shown below. The CpG island track, provided by the UCSC Genome Browser, was
generated using the unpublished cpglh program from Washington University (St. Louis) Genome Sequencing Center. B. Anti-sense interval
corresponds to the sequences overlapping the Riken transcript 5339438I03Rik. The green triangle identifies a 37 nt unique sequence insertion in
DBA. The two non-synonymous sequence variants in exon 9 sense transcript are shown. The SNP rs33860076 is the DBA marker at the centromeric
end of congenic lines 1jcdc, 1jcd, and 1jcdt. C. 39 UTR interval; vertical black bars represent positions of 52 B6 vs. DBA nucleotide sequence variants.
doi:10.1371/journal.pgen.1000137.g008
Figure 9. ClustalW Analysis of Lisch-like Homologs and the LSR Protein. ClustalW analysis was performed on the EMBL-EBI server (www.ebi.
ac.uk/clustalw/) using their default settings. We modified the display to emphasize exonic alignments. Positions of the two non-synonymous variants
in exon 9 of Ll are identified by blue shading. The non-homologous extension of mouse Lsr exon 6 (pink background) is shown beneath exon 7.
Mm_Ll; Mus musculus Lisch-like; Hs_C1orf32, Homo sapiens C1orf32; Dr_Ll, Danio rerio (zebra fish) Lisch-like ortholog; Mm_LSR, Mus musculus LSR-like
ortholog. Pair-wise similarity scores by isoform and domain are shown in Table S2.
doi:10.1371/journal.pgen.1000137.g009
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to visualize developing endodermal organs (Figure 10B) [73]. We
assessed b-cell development with an anti-insulin antibody at 48 hpf
or by insulin in situ hybridization at 24 hpf (not shown). To assess
morpholino specificity, we analyzed the effects of two separate,
non-overlapping morpholinos for each gene. Both morpholinos for
each ortholog independently produced similar phenotypes,
providing evidence that the effects (described below) were the
result of specific gene knockdown and not due to nonspecific
morpholino-related effects.
Figure 10B shows that both Lsr-like and Ll morpholinos injected
at 15 ng/embryo produced general developmental delay in the
endodermal organs, evidenced by a smaller liver, a smaller,
straighter intestine, and a smaller pancreas that does not extend as
much as in wild-type. The Lsr-like morpholinos disrupt b-cells
more severely (note ectopic insulin-positive cells in the cephalad
region of the pancreas) than do the Ll morpholinos (note the
milder local dispersion of insulin-positive cells); 48/72 and 25/144
embryos injected with morpholinos targeting Lsr-like and Ll,
respectively, displayed a scattered b-cell phenotype. These effects
were rarely observed in uninjected sibling embryos (0/25) or
embryos injected with a control morpholino (1/35). Lower doses
of Lsr-like and Ll morpholinos (,7–10 ng) resulted in a lower
frequency of b-cell scattering and higher doses (,20–25 ng)
resulted in embryonic toxicity, which is common with high doses
of morpholinos. The efficacy of the splice-blocking Lsr-like and Ll
morpholinos was assessed via RT-PCR and all were found to
strongly and specifically inhibit proper splicing of their respective
target transcripts at the 15 ng dose (not shown). In combination,
the expression analyses and morpholino knockdown studies
provide support for a role of Lisch gene family members in
endodermal development, and suggest specific effects on the
Figure 10. Expression Patterns and Morpholino Knockdown in Zebra Fish Embryos. A) Developmental expression of zebra fish Lisch-like
and Lsr-like orthologs. Lisch-like RNA was hybridized in situ to whole-mount zebra fish embryos at 48 hours post-fertilization (hpf), dorsal view with
anterior towards the top; and 72 hpf, lateral view with anterior towards the top, ventral towards the right and yolk removed. Lsr-like RNA was
hybridized at 48 hpf and 34 hpf. Ll panels show ventral views of embryos with yolks removed and anterior towards the top. Lsr-like panels show the
same image captured in the focal plane of the anterior (ap) and posterior (pp) pancreatic buds, respectively. i, intestine; ph, pharynx; pn, pronephric
ducts; l, liver; ap, anterior pancreatic bud; pp, posterior pancreatic bud; p, pancreas (after anterior and posterior bud fusion); b, brain; o, otic vesicle. B)
Morpholino knockdown of Lisch-like and Lsr-like orthologs at 48 hpf. Two dimensional ventral views (anterior towards top) of confocal stacks of
48 hpf embryos, uninjected or injected with 15 ng morpholino: control, Lsr-like sp1, and Lisch-like ATG. Gut-GFP transgene expression (green); insulin
immunolabelling (red).
doi:10.1371/journal.pgen.1000137.g010
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mammalian pancreas development has been shown earlier for
Ptf1a [74,75] and for Pdx1 [76].
W87* Stop Mutation of Ll in C3HeB/FeJ Mice
To examine phenotypes of mice segregating for a null allele for
Ll, we screened a repository of ENU-generated (N-ethyl-N-
nitrosourea) mutant sperm DNAs from 18,000 C3HeB/FeJ G1
males (Ingenium; http://www.ingenium-pharmaceuticals.com/)
for mutations in Lisch-like [77]. We detected a G/A substitution
that encodes an amber stop mutation at threonine-87 [W87*] and
also creates an EcoN1 cleavage site, which we used to genotype for
the mutation. By in vitro fertilization, we generated W87*
heterozygotes on the C3HeB/FeJ background, and bred these
animals to generate progeny that were homozygous wild-type (+/
+), homozygous mutant (2/2) or heterozygous (+/2) for the
W87* mutation. Progeny were born at the anticipated Mendelian
ratios, and the 2/2 animals did not appear grossly compromised.
To verify that the W87* homozygous mutant was hypomorphic
for LL protein, we compared a Western blot of hypothalamic
extracts prepared from C3HeBFeJ wild-type (+/+) and mutant
(2/2) mice, with a second blot of hypothalamic extracts prepared
from B/B and 1jc-D/D congenic mice. We probed both sets of
filters with a polyclonal rabbit antibody generated to a conjugated
polypeptide, corresponding to exons 7 and 8 of isoform 1, in the
predicted ICD of LL. As anticipated, LL protein was greatly
reduced in the brains of D/D vs B/B congenics and in the ENU-
treated W87* homozygotes vs. the wild-type animals (Figure 11A).
In mice at 14 days of age we can detect reductions in b-cell
replication rates that are similar to those seen in the DD congenic
lines (Figure 5B) There is a .2-fold difference in the proportion of
Ki67-positive b-cells in 14-day old wild-type (3.75%) vs.
homozygous W87* mice (1.75%), with heterozygotes intermediate
(2.5%) (Figure 11B). Plasma insulin concentrations in Ll W87*
homozygotes are reduced by the time of sexual maturation
(Figure 11C) and, consistent with this difference, at 50 days of age,
homozygous W87* males show an increased glucose AUC during
iPGTT (Figure 11D). A significant decrease in b-cell mass is also
detected in W87* homozygotes (1.05%6.117, n=3, p=.0113) v.
+/+ littermates (2.746.364; n=3) at 150 days of age.
It is important to note that these phenotypes were detected
despite the segregation of the mutation on a different background
strain (C3HeB/FeJ) than our congenics (C57BL/6J), and in the
absence of co-segregation of the Lep
ob. These preliminary data
strongly support the candidacy of Ll as the gene accounting for the
diabetes-related phenotypes of the DD congenic lines.
Discussion
Based upon a QTL analysis of modifiers of T2D in B6xDBA F2
Lep
ob/ob mice, we identified a novel gene, Lisch-like (Ll), whose
apparent effect on b-cell development, and possibly other aspects
of b-cell/islet biology, qualify it as a strong candidate mediator of
susceptibility to T2D. On the C57BL/6J strain background, the
presence of the DBA/2J congenic interval(s) produced mild
hypoinsulinemic hyperglycemia (in association with reduced b-
cell replication and mass). Our preliminary data in ENU-
mutagenized mice with a null Ll allele are consistent with a role
for LL in b-cell development.
Three of the Ll subcongenic lines (1jcd, 1jcdt and 1jcdc) contain
only DBA DNA 39 of exon 7, while line 1jc is DBA for the entire
gene and extends DBA for another 3 Mb 59 of Ll. We infer,
therefore, that coding and/or non-coding DBA vs. B6 variant(s) in
the region of DBA overlap accounts for the phenotypic differences
between the DBA congenic lines and animals segregating for B6
alleles in this region. In the region of overlap that includes the
DBA vs. B6 ‘‘variable region’’ (Figure 6), Ll is the only gene
showing anticipated differences in coding sequence and gene
expression. These findings strongly support, but do not prove, the
putative role of Ll alleles in conveying the phenotypic differences
seen between the various DD and BB congenic lines. The
phenotypes of the Ll W87* C3H mice also support our inferences
regarding the candidacy of Ll based upon the B.D congenics.
There are two non-synonymous SNPs in Ll within the region of
overlap among the congenic lines, in exon 9. However, their
effects on protein function are predicted to be minor and it is
unlikely that they determine the differences in either transcript
abundance or protein level seen in the congenics. Variants in other
regions of the gene are likely more relevant.
In the 59 UTR, all but one of the eight variants are in simple
repeats, where they are likely less significant.The interval underlying
the anti-sense transcript contains 45 D/B variants, including a long,
unique insertion. A regulatory role for the Ll anti-sense transcript is
suggested by the similar location of anti-sense transcripts at the 39
ends of the human C1orf32 (human ortholog of Ll)g e n e( e.g.,
DA322725 from hippocampus), the human LSR gene (DA320945,
also from hippocampus), the human ILDR1 gene (AW851103), and
the mouse Lsr gene (BY747866). Moreover, comparative inter-
species transcriptomic analysis has identified the 39 regions of
transcripts as important in anti-sense regulation, and conserved
overlap between species may be evidence of function [78]. For a
recent review of anti-sense regulatory mechanisms, see [79].
We identified 52 B/D variants in the 39 UTR, and it is estimated
that the stability of 35% of yeast transcripts are regulated by motifs
in the 39 UTR [80]. Regulatory motifs, at a similar density, have
been identified in the 39 UTRs of several mammals, including mice
[81]. A 39 UTR polymorphism between two putative mRNA
destabilizing motifs in PPPIR3 (muscle-specific glycogen-targeting
regulatory PP1 subunit) has been genetically [82] and functionally
[83] related to T2D. Variants in the 39 UTR may also affect
regulation by microRNAs (miRNAs). The 39 UTR is the target of
mammalian microRNAs (miRNAs) [84] and their relevance to
diabetes is underscored by the finding that mouse islet-specific miR-
375 affects insulin secretion [85].
The physiological role of Ll is unknown. Based upon the effects of
D alleles of Ll on b-cell proliferation rates, b-cell mass, in vivo insulin
release and glucose tolerance, (Figure 5) it is likely that Ll influences
early b-cell differentiation/turnover in a manner that predisposes
obese animals to later failure of b-cells by effects on mass and
possibly function [86,87]. The fact that these phenotypes are
substantially recapitulated in W87* Ll C3H mice supports this
inference.
In the neonatal rodent, extensive remodeling of b-cells occurs as a
result of simultaneous activation of both apoptosis and b-cell
replication [49]. Between 4 and 24 weeks, postnatally, b-cell mass
is estimated to increase 10 fold, related inpart to increased bodymass
[49]. Compensation for b-cell stress/loss in adult rodents is primarily
by b-cell hypertrophy and b-cell proliferation [51]. In rats, b-cell
proliferation rates decline from ,20% per day in pups, to ,10% per
day at 6–8 weeks,and to ,2% shortly thereafter [88]. However, even
this low rate of turnover apparently does not persist in adulthood.
Using continuous long term BrdU labeling in B6x129Sv and BALB/
C one year-old mice, replacement rates as low as ,1/1400 mature b-
cells/day have been reported [89]. Consistent with this finding,
pancreas mass in the mouse was recently shown to be irreversibly
constrained by the size of a progenitor pool in the embryonic
pancreatic bud [87]. These data suggest that b-cell mass established
in the first 6–8 weeks of life may be critical to the ability to meet
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hyperglycemia, and dyslipidemia. The molecular regulation of these
processes is incompletely understood, but even transient interruptions
may, based upon this formulation, result in permanent effects on cell
mass, or function, or both [90]. Hypoactivity of the candidate T2D
modifier gene (Ll) reported here could mediate such effects on
establishment of initial b-cell mass, and/or later responses of cell
hypertrophy/replication by b-cell-autonomous effects or in response
to an exogenous ligand for this putative receptor.
Observations that expression levels of Ll are most strikingly
affected in liver, the effects of the zebra fish knockdowns on
general endodermal development, and structure/function consid-
erations raised by the homologous LSR molecule [91], are
consistent with the possibility that the mechanism(s) by which Ll
conveys effects on cell mass/function might relate, in part, to
consequences of putative effects on hepatic development/
function. IGF1 [92] and hepatic growth factor [93] are examples
of such b-cell ‘‘hepatokines’’ affecting b-cell function.
Figure 11. Phenotypes of Mice Segregating for the W87* Allele of Lisch-like. A) Western analysis of Lisch-like in hypothalamus of 1jc and
homozygous W87* mice. The Western immunoblot shows differences in Ll expression in hypothalami of 1jc Lep
ob/ob B/B vs. D/D congenic males (left
panel), and between wild-type C3HeB/FeJ and W87* C3HeB/FeJ males (right panel). The right panel immunoblot was incubated with rabbit anti-LL
antiserum, prepared against a polypeptide corresponding to exons 7 and 8 of the ICD. The antiserum had been absorbed to fixed liver extracts from
knock-out mice in order to block non-specific proteins from interacting with the antibody. The LL transcript isomers are visible as a 65 and 70 kD
doublet in the B/B and C3HeB/FeJ wild-type lanes, but absent in the lanes of the 1jc-D/D congenic and C3HeB/FeJ W87* homozygous ENU mutants.
B) Percent Replicating b-cells in 14-day old ENU-mutagenized mice. The percentage of Ki67-positive b-cells was estimated in 14-day old C3HeB/FeJ
ENU-mutagenized mice, who were either homozygous wild-type (+/+), heterozygous (+/2), or homozygous for the W87* LL amber mutation (2/2).
At 14 days there was a 2-fold difference in the % of Ki67
+ b-cells in +/+ (3.75%) vs. 2/2 (1.75%) ENU W87* mice; +/2 were intermediate (2.5%). Non-
overlapping images of longitudinal pancreatic sections (200 mm apart) were acquired and analyzed using ImageJ software version 1.37 (NIH) to count
insulin-positive and Ki67
+ cells. Pancreatic weights of +/+ and 2/2 were not different. C) Fasting blood glucose (squares) and insulin/glucose ratios
(diamonds) in W87* (2/2) and wild-type (+/+) littermates. P-value ,0.05 for 2-tailed t-test at 63 days of age. Data points at other ages show trends.
D) ipGTT on 50-day old Surwit-fed B6.CH3. N3F1 W87* males. Glucose intolerance is seen in W87* mice. Mice were fasted overnight prior to dextrose
injection (50% dextrose solution, 0.5 g/kg, ip). Capillary tail bleeds were performed at the specified time points to determine circulating glucose levels
by glucometer (FreeStyle Flash, Abbott). Blood glucose concentrations that are marked with an asterisk are significantly different (t-test; p,0.05;
mean6SEM). Area under curve +/+ vs. 2/2 (p=0.02).
doi:10.1371/journal.pgen.1000137.g011
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Insight into the function(s) of the mouse Lisch-like protein may be
gained from similarities in structure, expression, and cellular
location with the human paralog, C1orf32, and with genes encoding
related trans-membrane receptors, Ildr1 [65] and Lsr [91]. Splicing
patternsofthesegenesgenerateisoforms,similartothoseofLl.Each
gene’s largest isoform includes an extra-cellular Ig-like domain, a
single TMD, and a similar set of ICDs in related order. In one
isoform of each protein, the TMD and cysteine-rich domains are
absent. An evolutionary, regulatory relationship is suggested by the
observation that the Ll-paralog and lldr1 are adjacent in the zebra
fish genome (Zv6 assembly, UCSC Genome Browser). All three
genesareabundantlyexpressedinthebrain,liver and pancreas(and
islets, where studied), and all are predicted to have 14-3-3
interacting domains (thus far experimentally verified for the human
LSR) [94]. Although 14-3-3 interacting domains may be present on
as many as 0.6% of human proteins, their occurrence on all of these
Lisch-related proteins is notable, since among known 14-3-3-
interacting proteins is phoshodiesterase-3B, which is implicated in
diabetes and pancreatic b-cell physiology [95,96,97], and others,
such as the Cdc25 family members, important in regulating cell
proliferation and survival [98,99].
T2D Genetics for Region of C1orf32: Chr1q23
The human ortholog of Ll, C1orf32, which is90% identicalto Llat
the amino acid level, maps to a region of Chr1q23 that has been
implicated in T2D in seven ethnically diverse populations including
Caucasians (Northern Europeans in Utah) [100], Amish Family
Study [101,102], United Kingdom Warren 2 study [103], French
families [104], and Framingham Offspring study [105], Pima
Indians [106], and Chinese [96] with LOD scores as high as 4.3.
The mouse congenic interval examined here is in the middle of, and
physically ,106smaller than, the 30 Mb human interval. Recent
analysis of the broad interval ascertained in Utah identified two
peaks, one of which, at D1S2762 (at 163.6 Mb), is just 12 kb
telomeric to the 59 end of C1orf32 [107]. The genes, and gene order,
are generally conserved between mouse and human in the region
syntenic to the congenic interval. The metabolic phenotypes
documented in human subjects with T2D linked to 1q23 resemble
diabetic phenotypes observed in congenic mice segregating for the
DBA interval in B6.DBA congenics examined here [108], suggesting
that the diabetes-susceptibility gene in congenic mice and human
subjects may be the same gene, or among the genes, acting in the
same genetic pathway(s). The syntenic interval in the Goto-Kakizaki
(GK) rat also correlates with diabetes-susceptibility [109].
Summary
We report the molecular cloning and preliminary characterization
of a candidate gene for a mouse QTL modifying T2D phenotypes in
mice. The gene, Lisch-like, is novel in structure among diabetes
susceptibility genes, and appears to modify b-cell development.
Amino acid sequence analysis is consistent with the possibility that
hypomorphism for this gene could affect b-cell development by a
number of possible molecular mechanisms. Proof of the role of this
gene in the imputed phenotypes and molecular processes awaits its
further analysis in transgenic animals and cell-based systems.
Methods
Animal Husbandry
Micewerehoused in a barrier facility in ventilatedPlexiglas cages
under pathogen-free conditions at room temperature (2261uC)
with a 12 h light/dark cycle. Mice were weaned at 21 d and given
ad libitum access to water and 9% Kcal fat Picolab Rodent Chow 20
(Purina Mills; www.purinamills.com/).The high fat diet protocol
used in some animals is described below. Columbia University’s
Institutional Animal Care and Use Committee (IACUC) approved
all protocols. After a 4 h morning fast, mice were sacrificed by
carbon dioxide asphyxiation and phenotyped for weight, naso-anal
length, and glycosuria. Blood was collected by cardiac puncture and
aliquoted into microfuge tubes containing an anticoagulant cocktail
of 10 ml of 1 mM EDTA and 1.5 mg/ml aprotinin (Sigma A-6279).
Plasma and red blood cell pellets were used to measure glucose,
insulin, and glycosylated hemoglobin as previously described [110].
Tissues (skeletal muscle, pancreas/pancreatic islets, liver, brain,
hypothalamus, kidney, spleen, heart, visceral fat, retroperitoneal fat)
were collected and immediately frozen in liquid N2, and stored at
280uC for further studies. Pancreata were dissected under
stereoscope, weighed, and fixed in Z-fix zinc-formalin fixative
(Anatech; www.anatechltdusa.com/).
Genotyping
Liver tissue or tail tips were used for genomic DNA isolation
according to standard procedures [111]. A mutation-specific assay
was used to confirm that all phenotypically obese animals were
Lep
ob/Lep
ob and all lean animals either +/+ or heterozygous at the
Lep locus [112] Animals were genotyped using MapPairs
Microstaellite Markers (Invitrogen; www.invitrogen.com/) as
previously described [113].
Mapping T2D-related Phenotypes in B6xDBA F2 Progeny
Maps were created using MapMarkerQTL (www.broad.mit.
edu/genome_software/other/qtl.html) on a dataset representing
404 obese F2 progeny of a B6xDBA cross segregating for Lep
ob at
120–150 days of age. The QTL for T2D was most significantly
associated with fasting blood glucose, glycosylated hemoglobin,
and islet histology in male mice to a region of Chr1, with peak
statistical significance at D1Mit110 at 169.6 Mb from the
centromere (p,10
28) (Figure 12). Other QTLs were identified
on other chromosomes (for example Chr5 at 78cM), but none had
as great an effect on the phenotype or demonstrated consistent
effects on all aspects of the phenotype. We tested for interactions
for QTLs and identified a modest interaction between the locus on
Chr1 and a second locus at D4Mit286 (p=0.008).
Figure 12. LOD Scores for Markers along Chromosome 1. LOD
scores are shown for fasting blood glucose (black) and pancreatic grade
(blue). Terminal phenotypes by genotype at D1Mit110 at 169.6 Mb are
summarized in Table S5.
doi:10.1371/journal.pgen.1000137.g012
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B6.DBA congenic mice were generated by intercrossing Lep
ob/
Lep
+ B6 X DBA mice from Jackson Laboratory (www.jax.org/) to
generate F1 progeny, followed by backcrossing to the recurrent B6
strain using a ‘‘speed congenic’’ approach in subsequent
generations [114]. At the eighth backcross, a genome scan was
performed in all breeders using polymorphic markers at 20 cM
intervals. In the mouse line that was continued, all non-contiguous
markers outside the DBA interval were homozygous B6. Over the
next two generations, there were two recombination events, one
that eliminated a telomeric portion of the DBA interval (line 1jc)
and one that preserved approximately half of the originally defined
DBA interval (line 1jcd). The 1jcd mouse was bred repeatedly to
B6 mice, giving rise, by meiotic recombination, to two additional
subcongenic lines (1jcdt and 1jcdc) (see Figure 1). Preservation of
the phenotypes present in the original B6xDBA and DBAxB6 F2/
F3 progeny was assessed by longitudinal and end-point measure-
ments of fasting glucose, insulin, glycosylated hemoglobin and islet
morphology. At N12, Lep
ob/+ mice B6/DBA (B/D) for the
respective congenic intervals were intercrossed to produce
N12F1 progeny. Obese progeny were used for fine mapping and
phenotyping experiments. Lep
ob/+ animals D/D for the congenic
interval were recurrently intercrossed or crossed to B6 Lep
ob/+
animals to generate ob/ob Lep
ob/Lep
ob animals with D/D and B/D
genotypes for the Chr1 interval, respectively.
Studies of Glucose Homeostasis
For longitudinal phenotyping studies, mice were fasted for 4 h
and restrained for blood collection by a trained individual. Blood
was collected from unanesthetized animals by capillary tail bleed
into heparinized tubes and stored at 280uC. Glucose was measured
with a FreeStyle Flash Blood Glucose Monitor (Abbott; www.
abbottdiabetescare.com/). Insulin was measured by ultra-sensitive
rat insulin ELISA (ALPCO; www.alpco.com/). HbA1c was
measured by affinity chromatography (Mega Diagnostics; www.
mega-dx.com/). Urine ketones were measured using Chemistrip
Test Strips (Roche Diagnostics; http://us.labsystems.roche.com/
index.shtml). For ipGTT, mice were fasted overnight and 0.5 g/kg
body weight of 50% dextrose was administered intra-peritoneally at
time 0. Plasma glucose was measured at 15–30 min intervals for
3 h, as above. Terminal phenotypic characterization consisted of
measurements of fasting glucose, insulin, glycosuria, and glycosy-
lated hemoglobin as previously described [110]. To control for
stress-induced hyperglycemia at the time of sacrifice, tail blood
glucose was also measured by glucometer one day prior to sacrifice.
High Fat and ‘‘Surwit’’ Diet Studies
High fat chow pellets (#D12492i: 60% kcal from fat, 20% kcal
from protein, 20% kcal from carbohydrate) and ‘‘Surwit’’ [115]
(#D12331i; 58% kcal from fat, 16.4% kcal from protein, 25.5%
kcal from carbohydrate) (Research Diets; www.researchdiets.com/
) were used as described in the text.
Morphometric and b-cell replication analysis of
Pancreatic Islets
Pancreatic tissues were dissected under stereoscope to avoid
contamination with adipose tissue, and weighed.
Islet Morphometry
Non-overlapping images of longitudinal pancreatic sections
were acquired and analyzed using ImageProPlus software version
5.0 (Media Cybernetics; www.mediacy.com/) to calculate insulin-
positive area, insulin-positive area as % total area, and number of
islets (defined by an area containing a minimum of 8 contiguous
insulin-positive cells). For b-cell replication studies, we recorded
the number of Ki67-positive or negative, insulin-positive cells.
Replication of b-cells was expressed as % of cells (Ki67-positive
and insulin-positive)/ total insulin-positive. For replication studies,
,100 islets were examined per animal from several different non-
overlapping sections through the pancreas. ImageProPlus or
Image J (1.37 V; NIH) were used to determine the relative area
of each section occupied by b-cells or the actual of number of b-
cells for each representative longitudinal pancreatic section (50 mm
apart) that had been immunochemically stained for insulin as
previously described [116]. We analyzed 5–7 sections from
different regions of the pancreas. Apoptosis rates were assessed
using the DeadEnd Fluormetric TUNEL System G3250 (Pro-
mega; www.promega.com/) TUNEL assay and cleaved Caspase-3
(Asp175) Antibody 9661S (Cell Signaling Technology; www.
cellsignal.com/).
Pancreatic Islet Isolation
Pancreatic perfusion and islet collection were performed as
previously described [117]. Each pancreas was perfused via the
bile duct with 1.5 mg/ml collagenase P (Roche Applied Science;
www.roche-applied-science.com/) and incubated at 37uC for
17 min. Following disaggregation of pancreatic tissue, pancreata
were rinsed with M199 medium containing 10% NCS. Islets were
collected by density- gradient centrifugation in Histopaque
(Sigma-Aldrich; www.sigmaaldrich.com/) [117], and washed
several times with M199 medium. For glucose-stimulated insulin
release studies [118,119], islets were incubated overnight in RPMI
medium 1640 (Invitrogen).
Glucose-Stimulated Insulin Secretion (GSIS)
The GSIS procedure has been described previously [120]. Islets
were hand-picked into tissue culture dishes containing cold Kreb’s
buffer (118.5 mM NaCl, 2.54 mM CaCl2, 1.19 mM KH2PO4,
1.19 mM MgSO4, 10 mM HEPES, pH 7.4), and 2% BSA
(Sigma-Aldrich), 5.5 mM glucose, and incubated overnight at
37uC. Islets were hand-picked and incubated another 15 min. in
Kreb’s buffer+BSA, containing 11.2 mM glucose. Hand-picked
islets are then resuspended in Kreb’s buffer plus BSA, supple-
mented with 2.8 mM glucose, and shaken at 37uC for 15 min.
The pellet was spun down gently and resuspended in triplicate (5–
10 islets each) in 500 ml Kreb’s buffer, supplemented with glucose
at final concentrations of 2.8 mM, 5.6 mM, 11.2 mM or
16.8 mM, or supplemented with 10 mM arginine and incubated
for 1 h in a water bath at 37uC with constant shaking (300 rpm).
After 1 h incubation, islets were gently pelleted and the
supernatant collected and assayed for insulin by ELISA. Islet
pellets were dissolved in high salt buffer (2.15 M NaCl, 0.01 M
NaH2PO4, 0.04 M Na2HPO4, EDTA 0.672 g/L, pH 7.4) and
sonicated at 4–5 W for 30 s and DNA concentration was
measured using a TKO100 fluorometer (Hoefer; www.hoeferinc.
com/) with Hoechst #33258 dye (Polysciences; www.polysciences.
com). Results were expressed as concentration of secreted insulin/
[DNA]/h.
Testing for Predicted Transcripts in cDNA Pools
Putative transcripts, identified from public annotation and local
sequencing, were validated by PCR-amplification from tissue-
specific cDNA pools prepared from male and female B6 mice.
Two cDNA pools were used: 1. An inclusive cDNA pool was
prepared from E7 and E20 fetuses and P1 pups, and included the
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tongue, spinal cord, kidney, testes/ovaries, pancreatic islets, whole
brain, hypothalamus, skeletal muscle, and liver. This pool was
used for transcript validation. 2. A diabetes-relevant cDNA pool,
from 90-day old mice, was comprised of only the following tissues
and organs: pancreatic islets, whole brain, hypothalamus, skeletal
muscle, liver, and adipose tissue. This pool was used to quantify
transcripts identified by computational approaches and the
microarrays. Nominal intron-spanning primers were generated
using the Primer3 program (www.genome.wi.mit.edu/cgi-bin/
primer/primer3_www.cgi). Amplification was first performed on
the diabetes-relevant pool at an annealing temperature of 60uC. If
we detected no PCR-product, we performed gradient temperature
PCR on the same pool using eight different annealing tempera-
tures from 58–68uC. Gradient temperature PCR was then used to
amplify the inclusive cDNA pool. If no product was detected in
this pool, a 2nd set of intron-spanning primers was used before we
interpreted negative amplification as failure to substantiate a
predicted transcript. Positive amplification products of predicted
sizes, and those that did not match the expected sizes, were gel-
purified and sequenced for confirmation. The final set of primer-
pairs is listed in Real-time qPCR.
Microarray Gene Expression Analysis
RNA extraction, purification, labeling, hybridization and
analysis were performed as described [121]. 10 BB and 10 DD
21-day old Lep
ob/ob 1jc males were dissected and RNA was
extracted from hypothalamus, liver, isolated islets, EDL muscle,
and soleus muscle. Individually labeled RNA (by mouse and
organ) was interrogated with Affymetrix MOE-430A expression
arrays. For further details, see legends to Table 1 and Figure 7. For
all transcripts in the region of interest, where possible, only probes
that spanned multiple exons and clearly represented each of the 14
genes in the interval were used. If .1 probe met these conditions,
we used only, the probe that gave the strongest signal. Organs
were grouped into two groups by genotype and were compared
using a two tailed T-test. The Affymetrix probe IDs selected for
this analysis are shown in Table S3.
Real-Time qPCR
Effects of the DBA congenic interval on the levels of confirmed
transcripts expressed in diabetes-relevant organs were assessed on
an organ-specific basis. We made separate pools from 90-day old
Lep
ob/ob 1jc D/D and B/B mice for each of the diabetes-relevant
organs (see above). Each individual organ pool was generated on 2
occasions from 5 mice. RNA was extracted from organs with
TRIzol acid-phenol reagent (Invitrogen). 2 mg of RNA were
reverse-transcribed using SuperScript III reverse transcriptase
(cDNA First Synthesis Kit, Invitrogen) with random hexamer
priming. The cDNA was diluted 4-fold using nuclease-free water
(QIAGEN; www.qiagen.com). 2 ml of diluted cDNA were
amplified by PCR in Roche LightCycler. A standard curve for
each transcript was generated using cDNA diluted 1:1, 1:10, and
1:100. We assessed the number of mRNA molecules in each
sample using the slope and intercepts of PCR product appearance
during the exponential phase of the PCR reactions optimized for
transcript-specific product using specific primers. Each sample was
run in triplicate in the same LightCycler run. Using LightCycler
Software, we calculated the crossing point (CP) for each sample.
The CP is the first maximum of the second derivative of the
fluorescence curve, and is equivalent to the number of cycles at
which the fluorescence first exceeds background. In the exponen-
tial phase, the relationship between CP and initial transcript
concentration is linear. We calculated relative concentration
ratios, normalized to actin, as follows:
R~ggene
DCPgene sample ref ðÞ ðÞ
.
gactin
DCPhg sample ref ðÞ ðÞ
In this expression, DCPgene is the CP of the gene in the sample
minus the CP of the gene in the relevant reference; DCPhg is the
CP of the housekeeping gene in the sample minus the CP of the
housekeeping gene in the reference (‘‘ref’’) sample; and g is the
efficiency (where 2 is perfectly efficient) as determined by the
negative slope of the plot generated when CP is plotted as a
function of the log of initial concentration determined in the
standard curve. Each CP listed is the mean of CP values of the
triplicates for each sample. Results are summarized in Table 1.
Primers used are listed in Table S4 (A).
Cloning and Sequencing of Lisch-like Isoforms
We amplified full-length Ll cDNAs from either B6 islets (isolated
by us) or from Clontech MTC Panels 1 #636745 and 3 #636757,
containing pooled multiple tissue cDNAs from 8–12 week old
BALB/c mice and from Swiss Webster embryos. In a final volume
of 50 ml, we added 0.5 ml LA Taq (TaKaRa; www.takara-bio.
com/) to a cocktail containing TaKaRa GC Buffer II, 400 mm
each dNTP, 1 ml cDNA and 1 ml each primer (300 ng/ml).
Primers are listed in Table S4 (B). Samples were cycled in an MJ
Tetrad Thermalcycler (BioRad; www.bio-rad.com) using a
Touchdown protocol of a 2 min. extension and decreasing
annealing temperature from 60uCt o5 5 uC for 10 cycles, followed
by 25 cycles with an annealing temperature of 55uC. Each sample
was TOPO TA cloned (Invitrogen) and plated. From all three
libraries, a total of 140 colonies were picked and grown overnight
in LB buffer. Inserts were amplified by colony PCR and sized by
gel-fractionation. Inserts representing each unique size were then
sequenced. The isoforms and the exons deleted (D): iso1 (intact 10
exons); iso2, D6; iso3, D4,5,6; iso4, D4; iso5, D5,6; iso6, D9; iso7,
D5,6,7,8,9.
Zebra Fish Analyses
A. Zebra Fish Strains and Embryo Culture. Zebra fish
and embryos were raised, maintained and staged according to
standard procedures [122]. The AB* (Eugene, OR) line and
Tg(gut GFP)s854 transgenic line (gutGFP; [73]) were used in
natural matings to obtain embryos. The gutGFP line was provided
by Didier Stainier. Embryos examined at stages later than 24 hpf
were maintained in embryo medium containing 0.003%
phenylthiourea to inhibit pigmentation.
B. Morpholino Injections. Morpholino antisense and
control oligonucleotides, listed in Table S4 (C), were purchased
from Gene Tools (www.gene-tools.com/) and injected into 1–
2 cell stage embryos at concentrations from 7–20 ng/embryo as
previously described [67].
C. RT-PCR. Total RNA was extracted from morpholino-
injected and uninjected sibling embryos at 29 hpf with TRIzol;
cDNA was synthesized with SuperScript II Reverse Transcriptase
(Invitrogen) using primer-pairs shown in Table S4 (D).
D. Immunofluorescence and RNA in situ Hybridi-
zation. Zebra fish gene sequences were amplified using the
primer-pairs shown in Table S4 (E) and cloned into the PSTBlue-1
vector (Novagen) and used for antisense probe synthesis with T7
RNA polymerase after XhoI linearization (Lsr-like)a n dS P 6
polymerase following BamH1 linearization (Lisch-like). Whole-mount
in situ hybridization was performed as described [123]. For
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4% paraformaldehyde for 2 h. After fixation, yolks were manually
removed and embryos were permeabilized in acetone at 220uCf o r
7 min. Embryos were washed briefly in PBS +0.1% Triton 6100
(PBSTx) and incubated for 1 h in antibody hybridization buffer
(PBSTxwith2%DMSO,2%BSAand2%sheepserum).Guineapig
anti-insulin antibody (Biomeda V2024) was diluted 1:1000 in
antibody hybridization buffer and incubated with embryos for 2 h
at rt. Following antibody hybridization, embryos were washed
e x t e n s i v e l yw i t hP B S T xa n di n c u b a t e dw i t hC y 3 - l a b e l l e dd o n k e y
anti-guinea pig secondary antibody diluted 1:500 in antibody
hybridization buffer for 2 h at rt. Embryos were washed extensively
with PBSTx and cleared in 80% glycerol/20% PBS. Images of
optical sections were captured using a confocal microscope and 2-D
projections were generated from optical sections using MetaMorph
software.
Computational Methods for Evaluating Effect of nsSNPs
We used five methods to compute the likelihood of a functional
change due to single amino acid substitutions (see Figure 9).
SNAP, PolyPhen, and SIFT predict changes in protein function
due to a single amino acid substitution. SNAP [57] is a neural-
network based method that considers protein features predicted
from sequence (e.g., residue solvent accessibility and chain
flexibility). Scores from 29t o+9 are estimates of accuracy of
prediction, computed using a testing set of ,80,000 mutants. A
low negative score indicates confidence in prediction of neutrality
(functional change absent), whereas a high positive score indicates
confidence in prediction of non-neutrality (functional change
present). Accuracy was computed for neutrals using the equation
below:
Accuracyneutral~
number of correct neutral predictions
total number of neutral predictions
PolyPhen considers structural and functional information and
alignments. Predictions are sorted into 4 classes: benign, possibly
damaging, probably damaging, and unknown.
SIFT predictions. SIFT [59] is a statistical method that only
considers alignments. Scores range from 0 to 1. Scores .0.05
indicate neutrality of a substitution.
PAM250 matrix substitutions. PAM matrix [124] (Percent
Accepted Mutations) reflects frequency of amino acid interchange
throughout evolution (by evaluating alignments of proteins in a
family). Scores range from a low of 28 for rare substitutions (e.g. W
to C) to a high of 17 (same residue found in almost all proteins in
alignment).
Percentage in alignment (PROFacc). The score is
reported as the difference in observed percentages of wild-type
and mutated residues in alignments against a non-redundant
UniProt [125] and PDB [126] database (at 80% sequence
identity).Scores range from 2100 (if the mutant is observed in
all instances) to +100 (if the wild type is observed in all instances); 0
if the mutant is observed as often as the wild type. Scores near 0
favor the likelihood of a mutation being neutral.
DBA BAC Shotgun Sequencing
BAC 95f9 DNA (5 mg) was fragmented to 1–5 kb using a
nebulizer supplied with the TOPO Shotgun Subcloning kit
(Invitrogen) and checked for size and quantity on an agarose gel.
The shotgun library was constructed with 2 mg of sheared DNA.
Blunt-end repair, dephosphorylation, ligation into PCR 4Blunt-
TOPO vector, and transformation into TOP10 Electrocompetent
E. coli were performed with the TOPO Shotgun Subcloning kit,
following the manufacturer’s protocol. Phenol:chloroform extrac-
tion of the dephosphorylated DNA was replaced with Qiagen
QIAquick PCR Purification spin columns (QIAGEN). Recombi-
nant colonies were selected by blue/white screening and incubated
in LB medium supplemented with 50 mg/ml ampicillin for 20 h at
37uC in 96-well deepwell plates. Plasmid miniprep was conducted
in 96-well plates using QIAGEN Turbo Miniprep kits on a
QIAGEN BioRobot 9600. DNA sequencing was performed on a
3730xl Genetic Analyzer (Applied Biosystems; www.appliedbio-
systems.com/) using BigDyeH Terminator v3.1 Cycle Sequencing
Kits with M13 forward and reverse sequencing primers.
Statistical Analyses
ANOVA and ANCOVA were used to assess effects of genotype
in congenic interval. Comparisons at individual time points, or
pairs of means were performed using Student’s t-test. P values are
2-tailed. The Statistica package (StatSoft; www.statsoft.com/) was
used for ANOVAE; Excel (Microsoft, http://office.microsoft.
com/en-us/default.aspx) for t-testing.
Western Blot
Hypothalamic extracts were prepared using M-PER Mammalian
Protein Extraction Reagent (Pierce Biotechnology, www.piercenet.
com/). Hypothalamic extracts (85 mg for B/B and D/D congenics
and 175 mg for wild-type and mutant ENU mice) were resolved by
8% SDS-PAGE, transferred to nitrocellulose membrane (Invitro-
gen). We generated a set of polyclonal rabbit antibodies (Covance
Research Products; www.covance.com) against the predicted ICD,
spanning residues 298–401 (exons 7,8) and verified that the a-ICD
rabbit antibodies detected the appropriate fusion proteins, with only
minor cross-reactivity in cultured cells. We hybridized the blot with
anti-LL anti-sera at a dilution of 1:5,000 in TBS/0.05%Tween/5%
milk (TBSTM) or with blocked anti-LL anti-sera diluted 1:10,000 in
TBSTM. To prepare blocked anti-sera, liver sections from C3HeB/
FeJ knock-out mice were fixed overnight in phosphate-buffered
paraformaldehyde at 4uC and rinsed in PBS. Sections equivalent to
one-third of a liver were fragmented and mixed with 1 ml anti-sera
diluted1/1000 inPBS/0.1%Triton. Liverfragmentswerespun out
and the supernatant was used to probe filters from ENU mice. We
detected bound antibody with horseradish peroxidase-coupled
antibody against rabbit IgG (Amersham Biosciences; www.amer-
shambiosciences.com) at a dilution of 1:5,000 using the SuperSignal
West Pico Chemiluminescent Substrate kit (Pierce Biotechnology).
Immunohistochemical and Immunofluorescnce Analysis
of Pancreatic Islets
For b-Cell Replication Studies. Pancreata were fixed
overnight in 10% formalin, embedded the specimens in paraffin,
and consecutive 5 mm-thick sections were mounted on slides. For
immunofluoresence and diaminobenzidine (DAB) staining of Ki67
and for insulin immunoreactivity, tissue sections were de-waxed in
xylene, hydrated through a descending ethanol series and
subjected to an antigen retrieval step using a heated citrate
buffer solution. Several longitudinal sections .100 mm apart were
used to assess b-cell replication and double staining for the nuclear
proliferation marker Ki67 and insulin. Sections were incubated
with Novocastra rabbit polyclonal anti-Ki67 antibody (Leica
Microsystems; www.leica-microsystems.com) diluted 1:200 and an
insulin polyclonal guinea pig anti-swine antibody (Vector Lab;
www.vectorlabs.com/) diluted 1:2000 overnight at 4uC.
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washed in PBS and incubated with secondary anti-guinea pig
IgG (1:200) and fluorescein isothiocyanate-conjugated rabbit
secondary antibody (1:200) (Vector Labs) for 1 hr and
counterstained with DAPI before the addition of mounting
medium. Non-overlapping images of longitudinal pancreatic
sections were acquired using a Nikon Eclipse microscope and
images imported into ImageJ (1.37 V, NIH) to count insulin-
positive and Ki67-insulin-positive cells. b-cell replication is
expressed as % Ki67-positive+insulin-positive/total insulin-
positive cells. For diaminobenzidine staining, sections were
incubated with secondary biotinylated rabbit and quinea pig
IgG for 1 hr and then subjected to an avidin:biotyinylated enzyme
complex (ABC Kit; Vector Labs) with DAB as substrate. Sections
were counterstained with hematoxylin. Images of pancreatic
sections were acquired using SpotAdvanced version 5 software
(Diagnostic Instruments; www.diaginc.com/) and analyzed using
Image Pro Plus software to calculate the % of b-cell area occupied
by Ki67-positive cells. We examined 30–50 islets per animal from
several non-overlapping sections through the pancreas.
Accession Numbers
Genbank (www.ncbi.nlm.nih.gov/(Genbank) accession numbers
for the M. musculus genes: Lisch-like, lipolysis-stimulated remnant
receptor-related (XM_001473525); Lsr (NM_017405); Ildr1
(NM_134109); Tada1l SPT3-associated factor 42 (NM_030245);
Pogk pogo transposable element with KRAB domain
(NM_175170); FMO13, flavin-containing monooxygenase family;
FMO-like (XM_136366); FMO9, flavin-containing monooxygen-
ase family; FMO-like (NM_172844) FMO12, flavin-containing
monooxygenase family; FMO-like (XM_136368);
C030014K22Rik, unknown (NM_175461); Uck2, uridine mono-
phosphate kinase (NM_030724); Tmco1, membrane protein of
unknown function (NM_001039483); Aldh9a1, aldehyde dehydro-
genase 9, subfamily A1 (NM_019993); Mgst3, microsomal
glutathione-S-transferase 3 (NM_025569); Lrrc52, leucine-rich
repeat (LRR) protein of unknown function (NM_00103382); Rxrg,
retinoid X receptor, gamma (NM_009107); Lmx1a, LIM homeo-
box transcription factor 1, a (NM_033652); Pbx1 (NM_008783);
H.sapiens C1orf32 (NM_199351); LSR (NM_015925); ILDR1
(NM_175924); D.rerio Ll ortholog, zgc:110016 (NM_001030192.1);
D. rerio Lsr ortholog, zgc:114089 (NM_001025472.1); R. rattus Lsr
(NM_032616).
The Genbank accession numbers for protein sequences: M.
musculus Lisch-like (amino acid residues 150–795, XP_001473575);
(Lsr) (NP_059101); Ildr1 (NP_598870); H. sapiens C1orf32
(NP_955383); LSR (NP_057009); ILDR1 (NP_787120); D. rerio
Lisch-like (NP_001025363); D. rerio Lsr (NP_001020643); R. rattus
Lsr (NP_116005)
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